Eton Pharmaceuticals Inc (ETON)
NASDAQ:ETON
US Market
Holding ETON?
Track your performance easily

Eton Pharmaceuticals (ETON) Financial Statements

409 Followers

Eton Pharmaceuticals Financial Overview

Eton Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.259; its P/E ratio is -22.77; Eton Pharmaceuticals is scheduled to report earnings on November 14, 2024, and the estimated EPS forecast is
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 9.07M$ 7.97M$ 7.03M$ 12.00M$ 5.30M
Gross Profit$ 5.63M$ 5.01M$ 4.40M$ 9.68M$ 3.35M
EBIT$ -2.99M$ 19.00K$ -548.00K$ 4.56M$ -4.54M
EBITDA$ -2.70M$ 296.00K$ -346.00K$ 4.80M$ -4.30M
Net Income Common Stockholders$ -3.04M$ -811.00K$ -579.00K$ 4.56M$ 13.02M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 17.69M$ 16.66M$ 22.07M$ 21.57M$ 14.71M
Total Assets$ 31.82M$ 30.79M$ 31.53M$ 30.93M$ 23.87M
Total Debt$ 4.80M$ 5.02M$ 5.78M$ 6.16M$ 6.53M
Net Debt$ -12.89M$ -11.63M$ -16.29M$ -15.41M$ -8.18M
Total Liabilities$ 18.36M$ 15.30M$ 14.63M$ 14.21M$ 12.69M
Stockholders Equity$ 13.46M$ 15.49M$ 16.89M$ 16.73M$ 11.24M
Cash Flow-
Free Cash Flow$ 1.25M$ -4.36M$ 873.00K$ 7.10M$ -1.55M
Operating Cash Flow$ 1.25M$ -2.47M$ 873.00K$ 7.10M$ -1.55M
Investing Cash Flow-$ -1.88M---
Financing Cash Flow$ -216.00K$ -378.00K$ -368.00K$ -246.00K$ -49.00K
Currency in USD

Eton Pharmaceuticals Earnings and Revenue History

Eton Pharmaceuticals Debt to Assets

Eton Pharmaceuticals Cash Flow

Eton Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis